Met XR

DRUG4 trials

Sponsors

Elcelyx Therapeutics, Inc., Woman's

Conditions

Diabetes Prevention in Women After GDM Who Are at High-riskHealthy SubjectsRenal InsufficiencyType 2 Diabetes Mellitus

Phase 1

Assessing the PK of Met DR, Met IR, and Met XR in Healthy Subjects

CompletedNCT02291510

Elcelyx Therapeutics, Inc.Healthy Subjects

Start: 2012-10-31End: 2012-12-31Updated: 2016-12-02

Phase 2

Assessing the Behavior of Met DR in Subjects With Kidney Dysfunction

CompletedNCT01658514

Elcelyx Therapeutics, Inc.Renal Insufficiency

Start: 2014-01-31End: 2014-06-30Updated: 2015-12-30

Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 Weeks

CompletedNCT01819272

Elcelyx Therapeutics, Inc.Type 2 Diabetes Mellitus

Start: 2013-04-30End: 2013-09-30Updated: 2017-03-15

Phase 3

Dapagliflozin and Metformin,Alone and in Combination, in Overweight/Obese Prior GDM Women

CompletedNCT02338193

Woman'sDiabetes Prevention in Women After GDM Who Are at High-risk

Start: 2015-09-22End: 2019-03-13Updated: 2019-06-11